An Intervention to Develop Interface Tools for Nutrigenomics

Adult Clinical Trial

Official title:

Building New Nutrigenomics Technology Interface Tools for Consumers and Health Professionals

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT03310814
• Other study ID #: 500692 - 16
• Status: Active, not recruiting
• Phase: N/A
• First received: August 29, 2017
• Last updated: October 10, 2017
• Start date: March 15, 2017
• Est. completion date: December 31, 2017

Study information

• Verified date: October 2017
• Source: Kwantlen Polytechnic University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study compares the efficacy of a non-practitioner assisted direct-to-consumer (DTC) self-driven approach to nutrigenomics versus a personalized practitioner-led method. The secondary aims are to use this data combined with participant feedback to generate more effective nutrigenomics-based products.

Description:

While nutrition is a widely accepted tool for the prevention of long-term health conditions, current approaches have not adequately reduced chronic disease morbidity. Nutrigenomics has great potential, however, it is complicated to implement. There is a need for products, derived from nutrigenomics, which are easily understood, accessible and utilized. The primary objective of this study is to compare the efficacy of a non-practitioner assisted direct-to-consumer (DTC) self-driven approach to nutrigenomics versus a personalized practitioner-led method. The secondary aims are to use this data combined with participant feedback to generate more effective nutrigenomics-based products.

Methods:

This 4-month study used a mixed-methods design that included: 1) a phase 1 randomized control trial that examined the effectiveness of a multi-faceted, nutrition-based gene test (components assessed included the major nutrients, food tolerances, food taste and preferences, and vitamins) in changing health behaviours; followed by 2) qualitative investigation that explored participants' experiences. The study recruited 57 healthy males and females (35-55 years) randomized as a 2:1 ratio where 38 received the intervention (gene-test results plus personalized nutrition report) and 19 were assigned to the control group (gene-test results report emailed). Both groups received follow-up emails with nutrition-related tips and reminders. The primary outcomes of interest measures included changes in diet (nutrients, healthy eating index), self-efficacy, quality of life and anthropometrics (BMI, waist:hip) measured at baseline, post-intervention (3 and 6 weeks), and the final visit. After the study has been completed, participants in the control group will also receive their personalized nutrition report.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 57
• Est. completion date: December 31, 2017
• Est. primary completion date: November 30, 2017
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 35 Years to 55 Years

Eligibility

Inclusion Criteria:

1. Adults, aged 35-55 years.

2. Ability to understand sign an informed consent and to give a buccal DNA swab.

3. Willing to improve their health.

4. Medically stable. Subjects diagnosed with diet-related chronic disease were able to enroll in the study, provided that their condition was stabilized or well controlled for at least six months at the time of the baseline visit. Determination of stabilized medical condition was based on established clinical guidelines (e.g., Canadian Diabetes Association Clinical Guidelines and Canadian Cardiovascular Society Guidelines).

Exclusion Criteria:

1. Currently on a therapeutic or restrictive diet (e.g., Atkins).

2. Diagnosis of 2 or more chronic diseases or unstable chronic disease as deemed by accepted clinical guidelines.

3. Clinical diagnosis of any mental health condition.

4. Current or former malignancy for which the participant has undergone resection, radiation therapy or chemotherapy within 5 years prior to baseline.

5. Diagnosis of any medical condition or disease, which in the opinion of the Principal Investigator (PI), may have either put the participant at risk, or influenced the results of the study or the participant's ability to participate in the study.

6. Diagnosis of any of the following medical conditions: HIV, COPD, severe/uncontrolled asthma, cystic fibrosis, bronchiectasis, interstitial lung disease, chronic renal failure, colon or small intestine problem, liver or kidney disease.

7. Currently enrolled or plan to be enrolled in another research study during the course of this investigation.

8. Planned or recent (within the last 12 months) bariatric surgery.

9. Current use of weight altering medication for the purpose of weight loss.

10. Uncorrected hypothyroidism or hyperthyroidism in the previous 12 months.

11. Alcohol or drug dependence during the previous 12 months.

12. Investigators and their immediate families. Immediate family was defined as a spouse, parent, child or sibling, whether biological or legally adopted.

13. Pregnant and/or breastfeeding.

14. Current smoker.

15. BMI = 35.

16. Any other health risk that may have impaired the study's ability to assess the impact of nutrigenomic information to improve diet and health.

Related Conditions & MeSH terms

• Adult

Intervention

Other:
• Personalized nutrition
Receives individualized nutrition information

Locations

Country	Name	City	State
Canada	Innovation Boulevard	Surrey	British Columbia

Sponsors (2)

Lead Sponsor	Collaborator
Kwantlen Polytechnic University	Natural Sciences and Engineering Research Council, Canada

Country where clinical trial is conducted

Canada, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Diet quality	Healthy eating index	8 weeks